Organization (Academic)
Clemson University
ClinicalTrials.gov lists Clemson University as lead sponsor of 18 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Clemson University Uploaded by Zscout370 at en.wikipedia, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Clemson University: 18 lead-sponsored trials and 1 legal-entity registration.
Disease areas (31)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Substance-Related Disorders | 8 |
| Anxiety Disorders | 5 |
| Opioid-Related Disorders | 5 |
| Pain | 5 |
| Cognitive Dysfunction | 3 |
Showing 5 of 31 disease areas.
Trials by start year as sponsor or collaborator (13)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 5 |
| 2023 | 5 |
| 2022 | 2 |
| 2021 | 5 |
| 2020 | 6 |
| 2019 | 1 |
| 2018 | 3 |
| 2017 | 4 |
Showing 10 of 13 years.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 0% hit target (n=6) | 17% on time (n=6) |
Journals published in (69)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| BMJ open | 3 |
| JMIR research protocols | 3 |
| Obstetrics and gynecology | 3 |
| BMC infectious diseases | 2 |
| BMC pregnancy and childbirth | 2 |
Showing 5 of 69 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 299 | 22 | 2025-09-09 |
Financing and grant events (248)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2026-05-26 | NIH grant | 331,268 | Reporter |
| 2025-09-12 | NIH grant | 350,000 | Reporter |
| 2025-09-10 | NIH grant | 2,217,769 | Reporter |
| 2025-09-03 | NIH grant | 47,505 | Reporter |
| 2025-08-28 | NIH grant | 685,932 | Reporter |
Showing 5 of 248 events.
Organization relationships (2)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Government of the United States of America | Co sponsors trial with | 1 |
| Penn State University | Co sponsors trial with | 1 |
Latest dated events (588)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-05-26 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2026-04-08 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-12 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-09-10 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-09-09 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 588 events.
Biomarker capability evidence (13)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| MAPT | Trial collaborator | Named in trial inclusion criteria |
| MCC | Trial collaborator | Named in trial exclusion criteria |
| MYCBP2 | Trial sponsor | Named in trial exclusion criteria |
| PAM | Trial sponsor | Named in trial exclusion criteria |
| PI3 | Trial sponsor | Named in trial exclusion criteria |
Showing 5 of 13 evidence rows.
Biomarkers this organization publishes on (106)
Shown in this order: most publications first.
Showing 5 of 106 biomarkers.
On Scientist.com
Clemson University is linked to 4 research suppliers in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with Clemson University - Plant Problelm Clinic and Nematode Assay Lab on Scientist.com
For prices, more details, or to contact Clemson University - Plant Problelm Clinic and Nematode Assay Lab, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.